Clovis Oncology reported $9.41M in Cost of Sales for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cost Of Sales Change
Abbvie ABBV:US $ 4142M 121M
Acadia Pharmaceuticals ACAD:US $ 2.95M 0.39M
Acorda Therapeutics ACOR:US $ 8.8M 2.83M
Agenus AGEN:US $ 543K 338K
Agios Pharmaceuticals AGIO:US $ 0.44M 0.1M
Anika Therapeutics ANIK:US $ 14.8M 0.09M
AstraZeneca AZN:LN 1904M 375M
Astrazeneca AZN:US 1.9B 375M
Clovis Oncology CLVS:US $ 9.41M 0.32M
Eli Lilly And LLY:US $ 1430.5M 641.6M
Esperion Therapeutics ESPR:US $ 9.18M 2.05M
GlaxoSmithKline GSK:LN 2136M 1509M
Halozyme Therapeutics HALO:US $ 15.92M 5.66M
Heron Therapeutics HRTX:US $ 11.36M 0.41M
Insmed INSM:US $ 16.4M 4.2M
Intrexon XON:US $ 17.1M 2.17M
Ligand Pharmaceuticals LGND:US $ 4.7M 7.28M
Merk MRK:US $ 3698M 1636M
Neurocrine Biosciences NBIX:US $ 4.8M 0.2M
Novartis NOVN:VX SF 3749M 6M
Pfizer PFE:US $ 8671M 1339M
Puma Biotechnology PBYI:US $ 14.92M 4.07M
Rigel Pharmaceuticals RIGL:US $ 1.04M 0.92M
Seattle Genetics SGEN:US $ 106.1M 18.47M
Ultragenyx Pharmaceutical RARE:US $ 8.27M 2.17M
Veracyte VCYT:US $ 25.03M 1.32M
YTE INCY:US $ 45.24M 8.02M